- Magellan Aerospace reported its third-quarter revenue at C$255.7 million, surpassing expectations.
- The revenue estimates had predicted C$246 million from two sources, which was exceeded by Magellan’s reported figures.
- Magellan Aerospace also reported earnings per share (EPS) of C$0.22.
- This EPS was higher than the estimated C$0.19, also based on two estimates.
- Analyst ratings for Magellan Aerospace include one buy and one hold, with no sell recommendations.
A look at Magellan Aerospace Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Magellan Aerospace is set for a promising long-term future, as indicated by its Smartkarma Smart Scores. With a strong Value score of 4, the company seems to be trading at an attractive valuation compared to its peers. This signifies that investors may find Magellan Aerospace to be a potentially solid investment in terms of its current stock price relative to its intrinsic value. Additionally, the Growth score of 5 suggests that the company is expected to experience robust growth in the coming years, potentially outperforming the market and expanding its market share.
Although the Dividend score is moderate at 2, indicating a lower focus on dividend payments, the Resilience and Momentum scores of 3 each point towards a company that is stable in the face of challenges and has a steady performance trajectory. Magellan Aerospace‘s expertise in supplying products and services to commercial and defense aircraft manufacturers worldwide positions it well for continued success in the aerospace industry, supported by its focus on aircraft structures, engines, and advanced energy systems.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
